{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:55:09Z","timestamp":1791140109277,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["T32 2015D006913"],"award-info":[{"award-number":["T32 2015D006913"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s11606-020-05779-1","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T22:02:36Z","timestamp":1585000956000},"page":"2375-2382","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Baseline Factors Associated with Mortality in Patients Who Engaged in Buprenorphine Treatment for Opioid Use Disorder: a Cohort Study"],"prefix":"10.1007","volume":"35","author":[{"given":"Danielle R.","family":"Fine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia A.","family":"Triant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis P.","family":"Baggett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua P.","family":"Metlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,23]]},"reference":[{"issue":"1","key":"5779_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","volume":"106","author":"L Degenhardt","year":"2011","unstructured":"Degenhardt L, Bucello C, Mathers B, et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction. 2011;106(1):32\u201351.","journal-title":"Addiction."},{"key":"5779_CR2","first-page":"1419","volume":"67","author":"LSP Scholl","year":"2019","unstructured":"Scholl LSP, Kariisa M, Wilson N, Baldwin G. Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017. MMWR Morb Mort Wkly Rep. 2019;67:1419\u20131427.","journal-title":"MMWR Morb Mort Wkly Rep"},{"issue":"50\u201351","key":"5779_CR3","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","volume":"64","author":"RA Rudd","year":"2016","unstructured":"Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016;64(50\u201351):1378\u20131382.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"5779_CR4","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","volume":"357","author":"L Sordo","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550.","journal-title":"BMJ."},{"key":"5779_CR5","unstructured":"Alderks CE. Trends in the Use of Methadone, Buprenorphine, and Extended-release Naltrexone at Substance Abuse Treatment Facilities: 2003-2015 (Update). The CBHSQ Report: August 22, 2017. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Rockville, MD."},{"issue":"1\u20132","key":"5779_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.drugalcdep.2009.05.021","volume":"105","author":"L Degenhardt","year":"2009","unstructured":"Degenhardt L, Randall D, Hall W, Law M, Butler T, Burns L. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: Risk factors and lives saved. Drug Alcohol Depend. 2009;105(1\u20132):9\u201315.","journal-title":"Drug Alcohol Depend."},{"key":"5779_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jsat.2015.04.008","volume":"57","author":"P Leece","year":"2015","unstructured":"Leece P, Cavacuiti C, Macdonald EM, et al. Predictors of Opioid-Related Death During Methadone Therapy. J Subst Abuse Treat. 2015;57:30\u201335.","journal-title":"J Subst Abuse Treat."},{"key":"5779_CR8","doi-asserted-by":"publisher","first-page":"b2225","DOI":"10.1136\/bmj.b2225","volume":"338","author":"C McCowan","year":"2009","unstructured":"McCowan C, Kidd B, Fahey T. Factors associated with mortality in Scottish patients receiving methadone in primary care: retrospective cohort study. BMJ. 2009;338:b2225.","journal-title":"BMJ."},{"issue":"3","key":"5779_CR9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jsat.2011.05.001","volume":"41","author":"G Cousins","year":"2011","unstructured":"Cousins G, Teljeur C, Motterlini N, McCowan C, Dimitrov BD, Fahey T. Risk of drug-related mortality during periods of transition in methadone maintenance treatment: a cohort study. J Subst Abuse Treat. 2011;41(3):252\u2013260.","journal-title":"J Subst Abuse Treat."},{"issue":"7","key":"5779_CR10","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/j.1360-0443.2005.01089.x","volume":"100","author":"MT Brugal","year":"2005","unstructured":"Brugal MT, Domingo-Salvany A, Puig R, Barrio G, Garcia de Olalla P, de la Fuente L. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction. 2005;100(7):981\u2013989.","journal-title":"Addiction."},{"issue":"1","key":"5779_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1046\/j.1360-0443.2002.00079.x","volume":"97","author":"M Gossop","year":"2002","unstructured":"Gossop M, Stewart D, Treacy S, Marsden J. A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction. 2002;97(1):39\u201347.","journal-title":"Addiction."},{"issue":"2\u20133","key":"5779_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.drugalcdep.2009.09.013","volume":"107","author":"E Peles","year":"2010","unstructured":"Peles E, Schreiber S, Adelson M. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel. Drug Alcohol Depend. 2010;107(2\u20133):141\u2013148.","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"5779_CR13","doi-asserted-by":"publisher","first-page":"e182943","DOI":"10.1001\/jamanetworkopen.2018.2943","volume":"1","author":"H Wen","year":"2018","unstructured":"Wen H, Hockenberry JM, Pollack HA. Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees. JAMA Netw Open. 2018;1(5):e182943.","journal-title":"JAMA Netw Open."},{"key":"5779_CR14","doi-asserted-by":"crossref","unstructured":"Schneeweiss S, Rassen JA, Brown JS, et al. Graphical Depiction of Longitudinal Study Designs in Health Care Databases. Ann Intern Med. 2019.","DOI":"10.7326\/M18-3079"},{"issue":"2","key":"5779_CR15","doi-asserted-by":"publisher","first-page":"e180217","DOI":"10.1001\/jamanetworkopen.2018.0217","volume":"1","author":"T Gomes","year":"2018","unstructured":"Gomes T, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. The Burden of Opioid-Related Mortality in the United States. JAMA Netw Open. 2018;1(2):e180217.","journal-title":"JAMA Netw Open."},{"key":"5779_CR16","unstructured":"SAMHSA. Using international classification of diseases (ICD) codes to assess opioid-related overdose deaths. 2018; https:\/\/www.samhsa.gov\/capt\/sites\/default\/files\/capt_resource\/using-icd-10-codes-to-assess-opioid-related-overdose-deaths.pdf. Accessed 31 Jan 2019."},{"key":"5779_CR17","unstructured":"National Center for Health Statistics. National Death Index user\u2019s guide. Hyattsville, MD; 2013. Available from: https:\/\/www.cdc.gov\/nchs\/data\/ndi\/NDI_Users_Guide.pdf. Accessed 25 Feb 2019."},{"issue":"11","key":"5779_CR18","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130\u20131139.","journal-title":"Med Care."},{"issue":"1","key":"5779_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/pds.3721","volume":"24","author":"B Niu","year":"2015","unstructured":"Niu B, Forde KA, Goldberg DS. Coding algorithms for identifying patients with cirrhosis and hepatitis B or C virus using administrative data. Pharmacoepidemiol Drug Saf. 2015;24(1):107\u2013111.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"5","key":"5779_CR20","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","volume":"35","author":"MV Ronan","year":"2016","unstructured":"Ronan MV, Herzig SJ. Hospitalizations Related To Opioid Abuse\/Dependence And Associated Serious Infections Increased Sharply, 2002-12. Health Aff (Millwood). 2016;35(5):832\u2013837.","journal-title":"Health Aff (Millwood)."},{"key":"5779_CR21","doi-asserted-by":"crossref","unstructured":"Schranz AJ, Fleischauer A, Chu VH, Wu LT, Rosen DL. Trends in Drug Use-Associated Infective Endocarditis and Heart Valve Surgery, 2007 to 2017: A Study of Statewide Discharge Data. Ann Intern Med. 2018.","DOI":"10.7326\/M18-2124"},{"key":"5779_CR22","unstructured":"The Executive Office of Health and Human Services. Masshealth Drug List Available from: https:\/\/masshealthdruglist.ehs.state.ma.us\/MHDL\/pubthera.do. Accessed 25 Feb 2019."},{"key":"5779_CR23","unstructured":"Centers for Disease Control. Drug overdose Data Files: Oral morphine milligram equivalents 2017 Available from: https:\/\/www.cdc.gov\/drugoverdose\/datafiles\/CDC_Oral_Morphine_Milligram_Equivalents_Sept_2017.xlsx. Accessed 25 Feb 2019."},{"key":"5779_CR24","unstructured":"Heslin KC, Elixhauser A, Steiner CA. Hospitalizations Involving Mental and Substance Use Disorders Among Adults, 2012. HCUP Statistical Brief #191. Agency Healthc Res Qual. 2015."},{"issue":"8","key":"5779_CR25","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1001\/jamainternmed.2014.2556","volume":"174","author":"JM Liebschutz","year":"2014","unstructured":"Liebschutz JM, Crooks D, Herman D, et al. Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial. JAMA Intern Med. 2014;174(8):1369\u20131376.","journal-title":"JAMA Intern Med."},{"issue":"8","key":"5779_CR26","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s11606-010-1311-3","volume":"25","author":"CW Shanahan","year":"2010","unstructured":"Shanahan CW, Beers D, Alford DP, Brigandi E, Samet JH. A transitional opioid program to engage hospitalized drug users. J Gen Intern Med. 2010;25(8):803\u2013808.","journal-title":"J Gen Intern Med."},{"key":"5779_CR27","doi-asserted-by":"crossref","unstructured":"O\u2019Donnell JK, Gladden RM, Seth P. Trends in Deaths Involving Heroin and Synthetic Opioids Excluding Methadone, and Law Enforcement Drug Product Reports, by Census Region \u2014 United States, 2006\u20132015. MMWR Morb Mortal Wkly Rep. 2017;66:897\u2013903.","DOI":"10.15585\/mmwr.mm6634a2"},{"issue":"8","key":"5779_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573\u2013577.","journal-title":"Ann Intern Med."},{"key":"5779_CR29","volume-title":"Mortality in the United States, 2017. NCHS Data Brief, no 328","author":"SL Murphy","year":"2018","unstructured":"Murphy SL, Xu JQ, Kochanek KD, Arias E. Mortality in the United States, 2017. NCHS Data Brief, no 328. Hyattsville: National Center for Health Statistics. 2018. https:\/\/www.cdc.gov\/nchs\/data\/databriefs\/db328-h.pdf. Accessed 18 Sept 2019."},{"issue":"2","key":"5779_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11606-006-0023-1","volume":"22","author":"DP Alford","year":"2007","unstructured":"Alford DP, LaBelle CT, Richardson JM, et al. Treating homeless opioid dependent patients with buprenorphine in an office-based setting. J Gen Intern Med. 2007;22(2):171\u2013176.","journal-title":"J Gen Intern Med."},{"issue":"16","key":"5779_CR31","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1001\/jama.283.16.2152","volume":"283","author":"SW Hwang","year":"2000","unstructured":"Hwang SW. Mortality among men using homeless shelters in Toronto, Ontario, JAMA. 2000;283(16):2152\u20132157.","journal-title":"JAMA."},{"issue":"8","key":"5779_CR32","doi-asserted-by":"publisher","first-page":"625","DOI":"10.7326\/0003-4819-126-8-199704150-00007","volume":"126","author":"SW Hwang","year":"1997","unstructured":"Hwang SW, Orav EJ, O\u2019Connell JJ, Lebow JM, Brennan TA. Causes of death in homeless adults in Boston. Ann Intern Med. 1997;126(8):625\u2013628.","journal-title":"Ann Intern Med."},{"issue":"3","key":"5779_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1001\/jamainternmed.2013.1604","volume":"173","author":"TP Baggett","year":"2013","unstructured":"Baggett TP, Hwang SW, O\u2019Connell JJ, et al. Mortality among homeless adults in Boston: shifts in causes of death over a 15-year period. JAMA Intern Med. 2013;173(3):189\u2013195.","journal-title":"JAMA Intern Med."},{"issue":"6","key":"5779_CR34","first-page":"E739","volume":"16","author":"V Bounes","year":"2013","unstructured":"Bounes V, Palmaro A, Lapeyre-Mestre M, Roussin A. Long-term consequences of acute pain for patients under methadone or buprenorphine maintenance treatment. Pain Physician. 2013;16(6):E739\u2013747.","journal-title":"Pain Physician."},{"issue":"2","key":"5779_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.7326\/0003-4819-144-2-200601170-00010","volume":"144","author":"DP Alford","year":"2006","unstructured":"Alford DP, Compton P, Samet JH. Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med. 2006;144(2):127\u2013134.","journal-title":"Ann Intern Med."},{"issue":"1","key":"5779_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10550490500418989","volume":"15","author":"RM Caldiero","year":"2006","unstructured":"Caldiero RM, Parran TV, Jr., Adelman CL, Piche B. Inpatient initiation of buprenorphine maintenance vs. detoxification: can retention of opioid-dependent patients in outpatient counseling be improved? Am J Addict. 2006;15(1):1\u20137.","journal-title":"Am J Addict."},{"issue":"4","key":"5779_CR37","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1370\/afm.2098","volume":"15","author":"J Dupouy","year":"2017","unstructured":"Dupouy J, Palmaro A, Fatseas M, et al. Mortality Associated With Time in and Out of Buprenorphine Treatment in French Office-Based General Practice: A 7-Year Cohort Study. Ann Fam Med. 2017;15(4):355\u2013358.","journal-title":"Ann Fam Med."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-05779-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11606-020-05779-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-05779-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T01:10:35Z","timestamp":1616461835000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11606-020-05779-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,23]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["5779"],"URL":"https:\/\/doi.org\/10.1007\/s11606-020-05779-1","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,23]]},"assertion":[{"value":"29 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Partners Healthcare Institutional Review Board approved this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Baggett receives authorship royalties from UpToDate. The other authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}